Supernus Pharmaceuticals, Inc.

1. 01

   Set a 52-week low on 4 Nov 2026

   Closed at $28.21 on 4 Nov 2026: 52.7% below the 52-week high of $59.68 (25 Feb 2026) and 5.5% above the low of $26.74 (4 Nov 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   Behind SPY and its sector fund XLV over 1 year

   1 month: −34.0% (SPY −1.0%, XLV +13.3%). 3 months: −34.8% (SPY −0.6%, XLV +17.0%). 1 year: −50.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: SUPN, SPY and XLV · as of 4 Nov 2026

3. 03

   Volume 5.2× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 6.6M shares was 5.2× the average of the 30 sessions before it (1.3M), as the price rose 0.2%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

4. 04

   RSI(14) at 19.9, 30 or below

   The 14-session relative strength index closed at 19.9 on 4 Nov 2026, its 2nd session at 30 or below. By convention a reading of 30 or below is called oversold and 70 or above overbought.

   Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

5. 05

   Below its 50- and 200-day averages

   The 4 Nov 2026 close of $28.21 was 32.5% below its 50-day average ($41.81) and 40.1% below its 200-day average ($47.07). It has closed below the 200-day for 54 sessions, since 19 Aug 2026. The 50-day average crossed below the 200-day on 9 Jun 2026, 102 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

At the 4 Nov 2026 close